A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures  Gang Wang, Na Zhao, Ben Berkhout, Atze.

Slides:



Advertisements
Similar presentations
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Advertisements

Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Volume 16, Issue 3, Pages (March 2008)
Volume 12, Issue 4, Pages (July 2015)
Molecular Therapy - Nucleic Acids
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
Volume 12, Issue 10, Pages (September 2015)
Volume 124, Issue 7, Pages (June 2003)
Expansion of Interstitial Telomeric Sequences in Yeast
Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency- Associated Genes  Steven Blinka, Michael H. Reimer, Kirthi Pulakanti,
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
Volume 20, Issue 5, Pages (May 2012)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Molecular Therapy - Methods & Clinical Development
Volume 7, Issue 1, Pages (April 2014)
Stable Transcriptional Repression and Parasitism of HIV-1
B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation  Kun Zhang,
Molecular Therapy - Nucleic Acids
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Volume 20, Issue 3, Pages (September 2016)
Volume 1, Issue 3, Pages (September 2013)
Volume 14, Issue 6, Pages (February 2016)
Molecular Therapy - Nucleic Acids
Volume 23, Issue 9, Pages (May 2018)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 9, Issue 3, Pages (March 2002)
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 22, Issue 9, Pages (February 2018)
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
Zongliang Gao, Elena Herrera-Carrillo, Ben Berkhout 
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Volume 11, Issue 6, Pages (May 2015)
Volume 17, Issue 1, Pages (January 2015)
Chromosomal Translocation Formation Is Sufficient to Produce Fusion Circular RNAs Specific to Patient Tumor Cells  Loelia Babin, Marion Piganeau, Benjamin.
Volume 128, Issue 3, Pages (March 2005)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 23, Issue 5, Pages (May 2018)
Volume 21, Issue 9, Pages (November 2017)
Volume 15, Issue 3, Pages (April 2016)
Flora Ambre Honoré, Vincent Méjean, Olivier Genest  Cell Reports 
RNA Polymerase II Activity of Type 3 Pol III Promoters
Volume 11, Issue 9, Pages (June 2015)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
John G. Purdy, Thomas Shenk, Joshua D. Rabinowitz  Cell Reports 
Volume 44, Issue 5, Pages (May 2016)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Merkel Cell Polyomavirus–Positive Merkel Cell Carcinoma Cells Do Not Require Expression of the Viral Small T Antigen  Sabrina Angermeyer, Sonja Hesbacher,
Molecular Therapy - Nucleic Acids
Harry I Segall, Eunsun Yoo, Richard E Sutton  Molecular Therapy 
Volume 9, Issue 3, Pages (November 2014)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Figure S1. Effect of lipid-based transfection reagents on genome editing Figure S1. Various amount of Cas9 protein and gRNA of HPRT were transfected.
Volume 16, Issue 11, Pages (September 2016)
Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells  Haiyan Ji, Panpan Lu, Baochi Liu,
Volume 18, Issue 9, Pages (September 2011)
Molecular Therapy - Nucleic Acids
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 9, Issue 4, Pages (April 2016)
Volume 9, Issue 5, Pages (May 2004)
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Volume 8, Issue 2, Pages (August 2003)
Molecular Therapy - Nucleic Acids
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Volume 17, Issue 5, Pages (October 2016)
Genome-Edited Triple-Recessive Mutation Alters Seed Dormancy in Wheat
Volume 6, Issue 3, Pages (March 1997)
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures  Gang Wang, Na Zhao, Ben Berkhout, Atze T. Das  Cell Reports  Volume 17, Issue 11, Pages 2819-2826 (December 2016) DOI: 10.1016/j.celrep.2016.11.057 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 17, 2819-2826DOI: (10.1016/j.celrep.2016.11.057) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 Targeting HIV-1 DNA with Single and Dual gRNAs (A) The position of the gRNAs targeting the sense and antisense strand are indicated above and below the HIV-1 proviral DNA, respectively. (B) Tested dual-gRNA combinations (gRNA I and gRNA II) with the distance between the target sites. (C) The efficiency of the single and dual gRNAs to silence HIV-1 DNA was tested in 293T cells transfected with plasmids expressing HIV-1 LAI, Cas9, and single or dual gRNAs. To quantify viral gene expression, the CA-p24 level was measured in the culture supernatant at 2 days after transfection. Average values (±SEM) of four experiments are shown. Cell Reports 2016 17, 2819-2826DOI: (10.1016/j.celrep.2016.11.057) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 HIV-1 Replication in Cas9- and gRNA-Expressing T Cells SupT1 T cells stably transduced with lentiviral vectors expressing Cas9 and single or dual gRNAs were infected with HIV-1 LAI virus and cultured for 60 (A and B), 114 (C), or 128 (D) days. (A) Virus replication in gGag1, gTatRev, gGag1+gTatRev, and control SupT1-Cas9 cells infected with 1 ng CA-p24 HIV-1 was monitored by measuring the CA-p24 level in the culture supernatant. (B–D) The day at which massive virus-induced syncytia were observed (reflecting breakthrough virus replication) was scored for four cell cultures infected with 1 (B), 6 (C), or 12 (D) ng CA-p24 HIV-1. When no virus replication was detected, we scored 60, 114, and 128 days, respectively. The average values ± SEM are shown. SupT1, control non-transduced cells. Cell Reports 2016 17, 2819-2826DOI: (10.1016/j.celrep.2016.11.057) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 Dual-gRNA-Mediated Inhibition of Breakthrough Replication Does Not Correlate with the Efficiency to Silence HIV-1 DNA but Correlates with Target Site Distance Correlation between the time required for breakthrough replication in the infected dual-gRNA SupT1 cells (data from Figure 2D) and (A) the level of HIV-1 gene expression measured in transiently transfected 293T cells (data from Figure 1C) and (B) the distance between the target sites (for dual gRNAs targeting protein-coding domains; distance shown in right panel in Figure 1B). The Pearson correlation coefficient (r) and p value (two-tailed) are shown. Cell Reports 2016 17, 2819-2826DOI: (10.1016/j.celrep.2016.11.057) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 Genotypic and Phenotypic Analysis of Cas9/gRNA-Targeted HIV-1 Provirus (A) Timeline of the genotype and phenotype assays performed for the gGag1+gTatRev and gGag1+gEnv2 protected SupT1 cultures that had been infected with HIV-1 LAI (12 ng of CA-p24 infections from Figure 2D). (B and C) For the genotype assay, the intracellular proviral DNA was isolated at 12 and 110 days after infection. The gRNA target regions were PCR amplified and sequenced upon TA cloning. Sequences of the individual TA cloned sites are shown in Figures S2 and S3. (B) The frequency of the WT target sequence in individual TA clones is shown for each gRNA target site. (C) The frequency of the WT sequence, nucleotide insertions, deletions, and substitutions observed for all analyzed gRNA target sites is shown. Sequences with both an insertion/deletion and nucleotide substitutions were scored as insertion/deletion. (D) For the phenotype assay, infected cells isolated at different times (16–97 days) were mixed with an equal amount of non-transduced SupT1 cells and cultured for 30 days. Syncytia formation in these cultures was monitored to detect rescue of replication-competent virus. +, syncytia detectable within the 30-day follow-up period; −, no syncytia detectable. Cell Reports 2016 17, 2819-2826DOI: (10.1016/j.celrep.2016.11.057) Copyright © 2016 The Author(s) Terms and Conditions